FDA applicant
Omrix Biopharmaceuticals, Ltd.
FDA records 3 decisions for Omrix Biopharmaceuticals, Ltd. (Ramat Gan, IL) from 2003 to 2009: 3 510(k) clearances. Most are in product codes FMF (Syringe, Piston) and FMI (Needle, Hypodermic, Single Lumen). Its devices cite 2 predicates, 0 of them its own earlier devices. 3 recalls are linked to its devices.
FDA’s records also spell it “Omrix Biopharmaceuticals, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Omrix Biopharmaceuticals, Ltd.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2009
2026 so far, outlined.
Recalls per year
1in 2018
Class I Class II/III not classified
Planning a device like Omrix Biopharmaceuticals, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report